Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2006-000503-41Phase 2Completed
Phase 2, randomised trial of progesterone in preterm birth (2 arms), sponsored by Rigshospitalet. Primary endpoint: Very early preterm birth incidence. Started Mar 2006; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2006-000503-41.